Company Analysis

NeoGenomics, Inc. (NEO)

Nasdaq: NEO · Services-Testing Laboratories · Fort Myers, FL · filing with the SEC since 1999
Grade4.4
◀ Past 4.4● Present 3.9▶ Future 4.9

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

24 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to NeoGenomics, Inc.’s names, not what it holds today.

Patents granted
24
24 utility, 1976 to Dec 31, 2025
Granted in 2025
6
Against 2 in 2024 and 3 in 2023
Applications published
45
9 of them in 2025
Names they are printed under
4
a subsidiary
By yearGrantedApplications published
'14'16'17'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology12
Computer technology3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Inivata Ltd. a subsidiary
named as the applicant on its applications, in GB. 1 more under the same name are not counted (printed in US)
0 granted
33 published
Inivata Ltd. a subsidiary
GB, as the owner printed on each patent
18 granted
2 published
NeoGenomics Laboratories, Inc. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
6 granted
3 published
NEOGENOMICS LABORATORIES, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0378907CANCER-ASSOCIATED GENETIC VARIANT FILTERING USING MUTATIONAL SIGNATURESComputer technologyInivata Ltd.
Nov 6, 20252025/0340926VARIABLE REPLICATE MULTIPLEX PCRComputer technologyInivata Ltd.
Aug 28, 20252025/0273296METHOD OF DETECTING CANCER DNA IN A SAMPLEComputer technologyInivata Ltd.
Aug 28, 20252025/0270629METHOD FOR AMPLIFYING A GENOMIC SAMPLEBiotechnologyInivata Ltd.
Jun 12, 20252025/0188547METHOD OF TREATING A CANCER PATIENT WITHOUT THE NEED FOR A TISSUE BIOPSYBiotechnologyInivata Ltd.
May 8, 20252025/0146064METHODS OF SEQUENCING NUCLEIC ACIDS AND ERROR CORRECTION OF SEQUENCE READSBiotechnologyInivata Ltd.
Feb 27, 20252025/0066847METHODS OF LABELLING NUCLEIC ACIDSBiotechnologyInivata Ltd. · patent 12,371,744 granted from it
Feb 13, 20252025/0051841METHODS OF LABELLING NUCLEIC ACIDSBiotechnologyInivata Ltd.
Jan 30, 20252025/0037792COMPUTATIONAL ASSESSMENT OF GENETIC VARIANT QUALITYComputer technologyInivata Ltd.
Dec 26, 20242024/0425930METHODS FOR SELECTIVE SEQUENCING OF CANCER DNABiotechnologyInivata Ltd.
What it applied for, 2024 to 2025: Biotechnology 7 · Computer technology 5 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton NEO · research, not advice